Prevalence and Factors Associated With Atrial Fibrillation in Patients With Type 2 Diabetes
Conditions: Atrial Fibrillation; Type 2 Diabetes Interventions: Other: Routine examinations Sponsors: Burapha University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials

Effect of denosumab on glucose metabolism in postmenopausal osteoporotic women with prediabetes: a study protocol for a 12-month multicenter, open-label, randomized controlled trial
This study aims to provide evidence on the efficacy of denosumab on glucose metabolism in postmenopausal women with osteoporosis and prediabetes. The results derived from this clinical trial may provide insight into the potential of denosumab in preventing T2D in high-risk populations.Trial registrationThis study had been registered in the Chinese Clinical Trials Registry. Registration number: ChiCTR2300070789 on April 23, 2023.https://www.chictr.org.cn. (Source: Trials)
Source: Trials - December 18, 2023 Category: Research Source Type: clinical trials

A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: LY3209590 Sponsors: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials

Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS)
Conditions: Obesity; Type 2 Diabetes Mellitus; Bariatric Surgery Sponsors: China-Japan Friendship Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials

Infections and Latent Autoimmune Diabetes in Adults
Conditions: Latent Autoimmune Diabetes in Adults; Type 2 Diabetes Sponsors: Karolinska Institutet; The Swedish Research Council; Swedish Council for Working Life and Social Research; Novo Nordisk A/S Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials

Chrono Nutrition and Insulin Resistance in Diabetes
Conditions: Diabetes Mellitus, Type 2 Interventions: Other: Chrono nutrition; Other: Standard Sponsors: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: semaglutide injection (HD1916); Drug: Ozempic Sponsors: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials

Tolerance to Islet Allotransplants in Diabetes
Conditions: Diabetes Mellitus Type 2 - Insulin-Treated Interventions: Biological: ToleraCell-001; Biological: ToleraCell-002; Drug: DFI-105; Drug: Etanercept; Drug: Tocilizumab; Drug: Sirolimus Sponsors: Diabetes Free, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials

Characteristics of Blood Glucose Variability in Patients With Type 2 Diabetes Mellitus and COVID-19
Conditions: COVID-19 Pneumonia; Type2diabetes Interventions: Other: Glucose variability Sponsors: Qilu Hospital of Shandong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials

A Study of Blood Metabolic Markers in Patients With Type 2 Diabetes Mellitus of Different Stages
Conditions: Diabetes Mellitus, Type 2 Interventions: Other: No intervention Sponsors: Peng Wu Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials

A Research Study in Saudi Arabia to Understand How the Dose Check App Used With Tresiba Treatment Helps to Control Blood Sugar Level
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Insulin degludec Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials

Restricted Eating Time in the Treatment of Type 2 Diabetes
Conditions: Type 2 Diabetes Interventions: Other: Time restricted eating Sponsors: Steno Diabetes Center Copenhagen; University of Leeds; Salk Institute for Biological Studies; University of Copenhagen; Glostrup University Hospital, Copenhagen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials

A Trial to Learn How Safe AZD9550 is in People With Type 2 Diabetes Who Are Overweight or Obese
Conditions: Non-alcoholic Steatohepatitis (NASH) Interventions: Drug: AZD9550; Drug: Placebo Sponsors: AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials

Effect of a Vegetarian Meal on the Physiology of Insulin Response in Patients With Type 2 Diabetes Mellitus and Obesity
Conditions: Type2diabetes; Obesity; Diet, Healthy; Nutrition, Healthy Interventions: Other: Vegetarian Meal Sponsors: IRCCS San Raffaele Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials

Application of a Protocol of Personalyzed Medicine in Patients With Type 2 Diabetes Mellitus and Multiple Doses of Insulin in Routine Clincal Care
Conditions: Type 2 Diabetes Mellitus; Multiple Dose Insulin Therapy Interventions: Other: Personalized treatment Sponsors: Hospital Arnau de Vilanova; Institut Catala de Salut Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials